Drug – bio-affecting and body treating compositions – Dentifrices
Reexamination Certificate
1998-10-02
2001-07-03
Gitomer, Ralph (Department: 1623)
Drug, bio-affecting and body treating compositions
Dentifrices
C435S211000
Reexamination Certificate
active
06254856
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to oral care compositions and products comprising a dextranase arid a mutanase, and optionally other enzymes.
The invention also relates to the use of the composition and product of the invention for the removal of dental plaque and preventing the formation of dental plaque.
BACKGROUND OF THE INVENTION
The formation of dental plaque leads to dental caries, gingival inflammation, periodontal disease, and eventually tooth loss. Dental plaque is a mixture of bacteria, epithelial cells, leukocytes, macrophages, and other oral exudate. Said bacteria produce highly branched polysaccharides which together with microorganisms from the oral cavity form an adhesive matrix for the continued proliferation of plaque.
As plaque continues to accumulate rock hard white or yellowish deposits arise. These deposits are called calcified plaque, calculus or tartar, and are formed in the saliva from plaque and minerals, such as in particular calcium.
Oral Polysaccharides
Oral polysaccharides are produced from sucrose introduced into the mouth, e.g. as a food or beverage constituent, by the action of cariogenic microorganisms, such as
Streptococcus mutans
or
Streptococcus sanguis
, growing in the oral cavity.
Said oral polysaccharides comprise water-soluble dextran, having large portions of &agr;-1,6 glucosidic linkage, and a major component of water-insoluble extracellular polysaccharides called “mutan” comprised of a backbone with &agr;-1,3-glycosidic linkages aid branches with &agr;-1,6-glycosidic linkages.
Mutan bind to hydroxyapatite (constituting the hard outer porous layer of the teeth) and to acceptor proteins on the cell surface of said cariogenic bacteria adhering to the teeth surface.
Mutanase
Mutanases are &agr;-1,3-glucanases (also known as &agr;-1,3-glucanohydrolases) which degrade the &agr;-1,3-glycosidic linkages in mutan. Mutanases have been described derived from Trichoderma (Hasegawa et al., (1969), Journal of Biological Chemistry 244, p. 5460-5470; Guggenheim and Haller, (1972), Journal of Dental Research 51, p. 394-402) and from a strain of Streptomyces (Takehara et al., (1981), Journal of Bacteriology 145, p. 729-735),
Cladosporium resinae
(Hare et al. (1978), Carbohydrate Research 66, p. 245-264), Pseudomonas sp. (U.S. Pat. No. 4,438,093), Flavobacterium sp. (JP 77038113),
Bacillus circulanse
(JP 63301738) and Aspergillus sp. A mutanase gene from
Trichoderma harzianum
has been cloned and sequenced (Japanese Patent No. 4-58889/A).
Dextranase
Dextranases are &agr;-1,6-glucanases (also known as 1,6-&agr;-D-glucan 6 glucanohydrolases) which degrade the &agr;-1,6-glycosidic linkages in dextran. Several microorganisms are capable of producing dextranases, among them fungi of genera Penicillium, Paecilomyces, Aspergillus, Fusarium, Spicaria, Verticillium, Helminthosporium and Chaetomium; bacteria of the genera Lactobacillus, Streptococcus, Cellvibrio, Cytophaga, Brevibacterium, Pseudomonas, Corynebacterium, Arthrobacter and Flavobacterium and yeasts such as
Lipomyces starkeyi.
Commercially available products include Dextranase 50 L from Novo Nordisk A/S produced by fermentation of strains of
Penicillium lilacium
. Dextranase 50 L is used in the sugar industry to break down dextran in raw sugar juice or syrup.
To be able to sufficiently guarantee the capability of chewing, e.g. foods, during a whole lifetime it is necessary to keep the teeth in a good condition and to obtain a good oral hygiene. This can be obtained by brushing the teeth frequently using toothpaste or the like. The mouth may further advantageously be rinsed with a mouth wash comprising anti-microbial agents.
To prevent the formation of dental caries, plaque, and tartar, it has been suggested to add a dextranase and/or a mutanase and/or other enzymes to oral care compositions and products.
U.S. Pat. No. 4,353,891 (Guggenheim et al.) concerns plaque removal using mutanase from
Trichoderma harzianum
CBS 243.71 to degrade mutan synthesized by cultivating
Streptococcus mutans
strain CBS 350.71 identifiable as OMZ 176. It is stated that the critical ingredient in dental plaque is water-insoluble polysaccharide with &agr;-1,3-glucosidic bonds and that such polysaccharide material termed mutan is not attacked by dextranase.
Guggenheim et al., (1972), Caries Res. 6, p. 289-297) discloses that the extent of the dental plaque of rats is not significantly affected by the simultaneous use of a dextranase and a 1,3-glucanase (mutanase).
Hare et al. (1978), Carbohydrate Research 66, p. 245-264, found that a synergistic effect is obtained when hydrolysing and solubilizing oral glucans with a bacterial dextranase in combination with bacterial &agr;-1,3 glucanase from
Cladosporium resinae.
U.S. Pat. No. 4,438,093 (The Research Foundation for Microbial diseases of Osaka) describes oral compositions comprising a dextranase and a &agr;-1,3-glucanase (mutanase), both being present in an amount of 0.5 to 100 enzyme units per gram of said oral composition, in an enzyme unit ratio of 1:2 to 2:1. Said dextranase is derived from a bacteria within the genus Corynbacterium and said &agr;-1,3-glucanase is derived from a bacteria-within the genus Pseudomonas.
GB 2,206,585 (Dental Chem Co LTD) described a teeth cleaning agent containing hydroxyapatite as polishing agent, with a laevanase, dextranase and mutanase immobilized on the hydroxyapatite.
U.S. Pat. No. 5,145,665 (Henkel) discloses a composition for the care of the mount and teeth comprising a dextranase and/or a 1,3-glucanase for cleaving polysaccharides in the mouth.
FR 2,651,433 (DANA) concerns dentifrice products containing a dextranase to acts on recent plaque, a mutanase to acts on old and insoluble plaque, and a mixture or other enzymes having bactericide action.
U.S. Pat. No. 5,320,830 (Proctor & Gamble) describes toothpaste compositions for the reduction of plaque and gingivitis comprising a) a surfactant, b) an enzyme, c) chelating agent d) a fluoride source, e) a silica abrasive and d) a carrier. The enzyme is an endoglucanase, papain, a dextranase and/or a mutanase.
SUMMARY OF THE INVENTION
It is the object of the present invention to provide oral care products which safely (i.e. without harming the tissue and structure of the oral cavity) and effectively prevent the formation of dental plaque and/or removes already deposited dental plaque.
In the first aspect the invention relates to an oral care composition comprising a
Paecilomyces lilacinum
dextranase and a mutanase. Further the invention relates to oral care products thereof, such as a dentifrice. Finally the invention relates to the use of a composition or product of the invention for preventing the formation of dental plaque or removing dental plaque.
REFERENCES:
patent: 4353891 (1982-10-01), Guggenheim et al.
patent: 4438093 (1984-03-01), Shimada et al.
patent: 4466954 (1984-08-01), Ichikawa et al.
patent: 5145665 (1992-09-01), Klueppel et al.
patent: 5320830 (1994-06-01), Lukcovic et al.
patent: 5637491 (1997-06-01), Campana et al.
patent: 5853702 (1998-12-01), Berka et al.
patent: 0 195 672 (1986-09-01), None
patent: 2 651 433 (1991-03-01), None
patent: 2 206 585 (1989-01-01), None
patent: 47-34148 (1972-08-01), None
patent: 94055662 (1998-05-01), None
patent: WO 98/00529 (1998-01-01), None
patent: WO 98/00528 (1998-01-01), None
patent: WO 98/18437 (1998-05-01), None
Sun J. The In Vitro Effects of Dextranase on Dental Plaque Produced by Streptococcus Mutans. Acta Microbiol Sin 28(3)242-248, 1988.*
Dialog Information Services, File 5, BIOSIS, Dialog Accession No. 7107517, Sun et al. (1998) Acta Microbiologica Sinica 28(3) :242-248.
File WPI, Derwent Accession No. 72-56480, Kojin Co. Ltd.
Dialog Information Services, File 351, WPI, Dialog Accession No. 004561593.
Dialog Information Services, File 155, Medline, Dialog Accession No. 02909591.
Budtz-Jørgensen et al. (1977), Scand. J. Dent. Res. 85:209-215.
Guggenheim et al. (1972), Caries Res. 6:289-297.
Gitomer Ralph
Lambiris Elias J.
Novo Nordisk A S
LandOfFree
Compositions for the removal of dental plaque does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for the removal of dental plaque, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for the removal of dental plaque will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2439789